Product NDC: | 0378-9639 |
Proprietary Name: | Butorphanol Tartrate |
Non Proprietary Name: | butorphanol tartrate |
Active Ingredient(s): | 10 mg/mL & nbsp; butorphanol tartrate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-9639 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075759 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120123 |
Package NDC: | 0378-9639-43 |
Package Description: | 2.5 mL in 1 VIAL, MULTI-DOSE (0378-9639-43) |
NDC Code | 0378-9639-43 |
Proprietary Name | Butorphanol Tartrate |
Package Description | 2.5 mL in 1 VIAL, MULTI-DOSE (0378-9639-43) |
Product NDC | 0378-9639 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | butorphanol tartrate |
Dosage Form Name | SPRAY |
Route Name | NASAL |
Start Marketing Date | 20120123 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | BUTORPHANOL TARTRATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |